메뉴 건너뛰기
New England Journal of Medicine
Volumn 366, Issue 17, 2012, Pages 1638-
Bevacizumab in neoadjuvant treatment for breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB;
EID: 84860148471     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (6)
References (3)
  • 1
    • 84856074107 scopus 로고    scopus 로고
    • Time to mandate data release and independent audits for all clinical trials
    • Haines IE, Gabor Miklos GLG. Time to mandate data release and independent audits for all clinical trials. Med J Aust 2011;195:575-7.
    • (2011) Med J Aust , vol.195 , pp. 575-577
    • Haines, I.E.1    Gabor Miklos, G.L.G.2
  • 2
    • 80054016807 scopus 로고    scopus 로고
    • The Avastin story
    • Sekeres MA. The Avastin story. N Engl J Med 2011;365:1454-5.
    • (2011) N Engl J Med , vol.365 , pp. 1454-1455
    • Sekeres, M.A.1
  • 3
    • 79960240479 scopus 로고    scopus 로고
    • Reputation and precedent in the bevacizumab decision
    • Carpenter D, Kesselheim AS, Joffe S. Reputation and precedent in the bevacizumab decision. N Engl J Med 2011;365(2):e3.
    • (2011) N Engl J Med , vol.365 , Issue.2
    • Carpenter, D.1    Kesselheim, A.S.2    Joffe, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.